Rajapravartini Vati: Benefits, Evidence, Dosage & Safety

Pregnancy warning, read first: Rajapravartini Vati is a classical emmenagogue, a formulation intended to promote menstrual flow. Do not use it during pregnancy or when pregnancy is possible. It contains aloe, which the US National Center for Complementary and Integrative Health warns may be unsafe taken orally during pregnancy and breastfeeding, plus mineral ingredients (purified ferrous sulfate and borax). A missed period must be evaluated by a clinician, including pregnancy testing, before anyone considers an emmenagogue. (NCCIH)

TL;DR

Rajapravartini Vati is a classical herbo-mineral Ayurvedic tablet (Bhaishajya Ratnavali) combining purified aloe, ferrous sulfate, borax and asafoetida, traditionally used to promote menstrual flow. Small human studies on scanty or painful periods report improvements but are tiny or uncontrolled. It must not be used in pregnancy or when pregnancy is possible: it is an emmenagogue containing aloe and minerals. (60 words. Sources: World Journal of Pharmaceutical Research 2022; Int Ayurvedic Med J 2020; NCCIH.)

What it is

Rajapravartini Vati (also spelled Rajah Pravartini Vati; also called Kasisadi Vati) is a herbo-mineral Ayurvedic tablet attributed to the Bhaishajya Ratnavali under the Stri Roga (women's disorders) section: verse numbering varies by edition, so citations differ between sources (World Journal of Pharmaceutical Research).

A 2022 pharmaceutical study prepared it per the classical method: equal quantities of shodhita kasisa (purified ferrous sulfate), shodhita tankana (purified borax), shodhita hingu (purified asafoetida resin, Ferula assa-foetida) and musabbar/kanyasara (aloe material, Aloe vera), given three bhavanas (triturations) with kumari svarasa, fresh aloe juice, and rolled into pills of chanakamatra (chickpea) size (WJPR). A clinical paper confirms the same four ingredients: kasisa (ferrous sulfate), tankana (borax), kumari (aloe vera) and hingu (Int Ayurvedic Med J).

Note the shodhita (purified) prefix on the mineral ingredients: classical pharmacy requires specific purification procedures before such ingredients are considered fit for use, and the preparation study emphasizes this processing (WJPR).

Traditional use

These are traditional claims, not clinical proof.

Classically, Rajapravartini Vati is described for artava kshaya, scanty or absent menstrual flow, with the name itself meaning "that which promotes rajas" (menstrual flow). The 2022 preparation paper notes that every ingredient is credited in the tradition with rajapravartaka (flow-promoting) properties, and that the formula is "told by Neelakanth" in the classical lineage (WJPR). These traditional attributions are not evidence that it works.

What modern research says

Oligomenorrhea (single-arm trial)

A 2020 single-arm trial enrolled 30 adults with oligomenorrhea (infrequent/scanty periods) and gave 250 mg twice daily for three months, reporting improvements in menstrual parameters (clinical trial PDF). With no control group, it is impossible to know how much of the improvement was the tablet, natural variation, or placebo effect.

Primary dysmenorrhea (placebo-controlled study)

A 2020 clinical study (Namrata Patel et al., Int Ayurvedic Med J, doi:10.46607/iamj1008102020) tested Rajapravartini Vati in primary dysmenorrhea (kashtartava), using 250 mg twice daily from day 21 of the menstrual cycle through three days of menstruation, for three cycles, against placebo (IAMJ). This is the strongest human evidence available for the formulation: but it is a single small study, and single small studies need independent replication before their results can be trusted.

Small randomized open study

A small randomized open-label study in 15 participants used 500 mg twice daily for 60 days (JETIR). Fifteen participants is too few for reliable conclusions, and the open-label design adds bias risk.

Animal evidence: estrogenic activity

A rat uterotrophic assay reported estrogenic activity for the formulation (bibliomed). This is animal evidence only: uterine-tissue responses in rats do not establish hormonal effects, beneficial or harmful, in women.

What the evidence does not support

The evidence does not establish that Rajapravartini Vati regulates cycles, treats infertility, or "improves chances of conceiving": conception-related claims sometimes made for it have no cited human-trial support. Traditional emmenagogue use is not clinical proof, and none of these studies tested safety in pregnancy (which, per the warning above, is a contraindication, not a research gap to explore).

Dosage

The regimens below are what published studies used: not recommendations. Because this is a mineral-containing emmenagogue, it should only be considered under qualified practitioner supervision, and never in pregnancy.

Safety & contraindications

Pregnancy: Do not use Rajapravartini Vati during pregnancy, when pregnancy is possible, or while trying to conceive. It is specifically formulated as an emmenagogue (menstrual-flow promoter), and its aloe content adds an independent concern: the US National Center for Complementary and Integrative Health states that aloe taken orally, as gel, latex, or whole-leaf, may be unsafe during pregnancy and breastfeeding (NCCIH). Do not use it to attempt to end a pregnancy: that is dangerous and requires medical care, not an herbal tablet.

Before use for a missed period: a missed or delayed period must first be evaluated by a clinician, including pregnancy testing. Taking an emmenagogue without ruling out pregnancy is unsafe (NCCIH).

Other safety points:

FAQs

What is Rajapravartini Vati?

It is a classical herbo-mineral Ayurvedic tablet attributed to the Bhaishajya Ratnavali, made from equal parts purified ferrous sulfate (kasisa), purified borax (tankana), purified asafoetida (hingu) and aloe (musabbar), triturated with fresh aloe juice and rolled into pills (WJPR). It is also called Kasisadi Vati, and its name means "promoter of menstrual flow."

Does it work for scanty or painful periods?

Evidence is weak but suggestive. A 30-person uncontrolled trial in oligomenorrhea and a small placebo-controlled study in primary dysmenorrhea reported improvements, and a 15-person open study used a higher dose (trial PDF; IAMJ; JETIR). Small, mostly uncontrolled studies with no independent replication cannot establish efficacy: and animal estrogenic-activity data does not translate to women (bibliomed).

Is Rajapravartini Vati safe in pregnancy?

No. It is an emmenagogue, designed to promote menstrual flow, and must not be used during pregnancy or when pregnancy is possible. Additionally, the NCCIH warns that oral aloe (gel, latex, or whole-leaf) may be unsafe in pregnancy and breastfeeding (NCCIH). It must never be used to attempt to end a pregnancy; that requires medical care.

I missed my period — can I take it to bring it on?

Not before a clinician evaluates you. A missed period needs pregnancy testing and clinical assessment first, because taking an emmenagogue without ruling out pregnancy is unsafe: and this product is contraindicated in pregnancy (NCCIH). See a doctor or qualified practitioner rather than self-treating.

What dose was used in studies?

Three published regimens: 250 mg twice daily for 3 months (oligomenorrhea trial); 250 mg twice daily from cycle day 21 through 3 days of menstruation for 3 cycles (dysmenorrhea study). And 500 mg twice daily for 60 days (small open study) (trial PDF; IAMJ; JETIR). These are research regimens, not recommendations: and none applies in pregnancy.

Are the mineral ingredients safe?

The formula contains purified ferrous sulfate and borax: minerals that classical Ayurvedic pharmacy requires to undergo shodhana (purification) before use (WJPR). That processing is exactly why only licensed-manufacturer products, taken under qualified practitioner supervision, should ever be considered. Do not buy loose powders or unlabelled tablets.

Sources

Disclaimer

This article is for educational purposes only and is not medical advice. Herbal products can interact with medications and are not suitable for everyone. Talk to a qualified healthcare practitioner before use — especially if you are pregnant, breastfeeding, managing a medical condition, or taking prescription medicines.